Global Anti-Malarial Drugs Market, 2016-2018 & 2027 - Increasing Awareness in Early Symptoms, Constant Monitoring and Easy Availability of Therapeutics - ResearchAndMarkets.com

December 4, 2018

DUBLIN--(BUSINESS WIRE)--Dec 4, 2018--The “Anti-Malarial Drugs Market” report has been added to ResearchAndMarkets.com’s offering.

The Global Anti-Malarial Drugs market reached USD 742.5 Million in 2016 by registering a CAGR of 3.2% across the globe. Moreover, the market is expected to garner USD 1,049.5 Million by the end of 2027.

The Global demand for Anti-Malarial Drugs is increasing due to massive growth of healthcare industry across the globe. Further, increasing awareness about early symptoms, constant monitoring and easy availability of therapeutics is key growth driver for Global Anti-Malarial Drugs market over the forecast period.

Global Anti-Malarial Drugs market is segmented on the basis of Anti-Malarial Activity Tissue Schizonticides, Blood Schizonticides, Gametocytocides, Sporontocides & Others. Among these segments, Gametocytocides segment (60.3% share in 2016) occupies the largest market of Anti-Malarial Drugs across the globe.

Further, Global Gametocytocides segment is anticipated to reach USD 639.7 Million by the end of 2027 from USD 448 Million in 2016. Moreover, this segment is anticipated to flourish at a CAGR of 3.39% over the forecast period. In addition, Blood Schizonticides segment of Anti-Malarial Drugs is expected to achieve Y-o-Y growth rate of 3.4% in 2027 as compared to previous year.

Mylan Labs, Cipla & GlaxoSmithKline Plc are some of the prominent players of Anti-Malarial Drugs market.

Key Topics Covered:

1. Executive Summary

2. Research Methodology

3. Risk Analysis

4. Recent Changes and Development in Anti-Malaria Drugs Market by Geography

5. Top Countries with Highest demand for Anti-Malaria Drugs - By Region

6. Global Anti-Malaria Drugs Market Size (USD Million) and Forecast, 2016-2027

7. Market Dynamics & Its Impact Analysis

8. Global Market Segmentation Analysis

9. Porter’s Five Force Model Analysis

Companies Mentioned

Mylan Labs Cipla GlaxoSmithKline Novartis Roche Bayer AG Lincoln Pharmaceuticals Strides Pharma Science Glenmark Pharmaceuticals Alliance Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/research/n9bk5x/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181204005715/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Diseases Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/04/2018 10:15 AM/DISC: 12/04/2018 10:15 AM


Update hourly